Academic Journal

In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure

التفاصيل البيبلوغرافية
العنوان: In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure
المؤلفون: Abumoawad, Abdelrhman, Saad, Ahmed, Ferguson, Christopher M., Eirin, Alfonso, Herrmann, Sandra M., Hickson, LaTonya J., Goksu, Busra B., Bendel, Emily, Misra, Sanjay, Glockner, James, Dietz, Allan B., Lerman, Lilach O., Textor, Stephen C.
المساهمون: National Institutes of Health
المصدر: Kidney International ; volume 97, issue 4, page 793-804 ; ISSN 0085-2538
بيانات النشر: Elsevier BV
سنة النشر: 2020
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.kint.2019.11.022
الاتاحة: http://dx.doi.org/10.1016/j.kint.2019.11.022
https://api.elsevier.com/content/article/PII:S0085253819312189?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0085253819312189?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.B2232628
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.kint.2019.11.022